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Andersson's and H~iyry's description in 1973 (1) of a  secondary-type response 
in vitro after "sensitization" of lymphocytes in mixed leukocyte cultures (MLC)  ~ 
opened  an  area  of immense  interest.  The  basic  observation  now  studied  in 
several laboratories (2-7) was that after a period of in vitro incubation in MLC, 
at a time when the proliferative and cell-mediated lympholysis (CML) responses 
have either returned to background levels or at least diminished markedly from 
the peak reactions, restimulation of the cells remaining in culture with lympho- 
cytes of the original  sensitizing cell donor results in rapid and strong develop- 
ment of proliferative and cytotoxic responses. 
In  a  primary  MLC-CML reaction,  it appears that  major histocompatibility 
complex (MHC) LD antigens  are for the most part responsible for the stimula- 
tion of proliferative events in a subpopulation of responding T cells, the prolifer- 
ating helper cells (PHCs). The MHC SD antigens, or products of loci very closely 
linked to those determining the SD antigens,  are primarily responsible for the 
activation  of,  and  serve  as  targets  for,  a  second  lymphocyte  subpopulation, 
cytotoxic T cells (CTLs) in the CML phase.  We have recently obtained prelimi- 
nary data in man (4) which suggest that after sensitization  of a  primary MLC 
with both MHC SD and LD differences, restimulation of the secondary culture 
with an LD difference will result in not only a secondary proliferative response 
but a  significant  and rapid redevelopment of cytotoxicity against the SD anti- 
gens present in the primary sensitization  (5).  In the present report we extend 
and more critically analyze these findings in mice and present results of experi- 
ments designed to elucidate the role of MHC LD and  SD components in the 
secondary stimulation system. 
Materials  and Methods 
Mice.  Inbred strains used in this study and maintained in this laboratory are B10.A (kkdd), 
B10.T(6R) (qqqd), AQR (qkdd), C57BL/10 (bbbb), B10.S (ssss), B10.D2 (dddd), B10.G (qqqq),  and 
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16836 and National Foundation-March of Dimes grant CRBS 246. 
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B10.BR (kkkk).  Lowercase italic letters in parentheses after the strains refer to the K, I, S, and D 
regions of the MHC and represent their H-2 designation. 
We refer to two mouse strains as "LD different" if, with respect to H-2, they differ for the strong 
LD locus in the I  region but are identical for H-2K and H-2D. Two mice are called SD different if 
they differ for the K  and/or D  region and are/-region identical. The designation SD and LD are 
simply terms we use to allow one to differentiate between MHC determinants that may have 
different biological roles. The terms should not imply that a function associated with LD cannot 
also be associated with SD; for instance, that SD antigens cannot induce lymphocyte proliferation. 
Primary Sensitization.  Mouse spleen cell allosensitization in MLC has been described else- 
where (8). Briefly, 50 x  10  ~ responding spleen cells are cultured with 50 x  10  ~ mitomycin C-treated 
stimulating spleen cells in 20 ml of EHAA media containing 2-mercaptoethanol (5 x  10  -5 M) and 
0.5%  mouse serum (from the responder strain) in upright no. 3013 Falcon tissue culture flasks 
(Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) in 5% CO2 in air (humidified) (8). After 5 days 
in culture, the proliferative MLC response is measured by the incorporation of [3H]thymidine (2 
~Ci/culture)  into triplicate 200-ftl  samples (multiple automated sample harvestor; Otto Hiller 
Co., Madison, Wis.) of reacting cells and expressed as the mean counts per minute _+  standard 
deviation (SD). The primary CML response is also determined on day 5. 
Secondary  Sensitization.  Spleen cell cultures prepared as for primary sensitization are incu- 
bated for 13-17  days at which time they are assayed to determine the remaining MLC (prolifera- 
tive) and CML activity. The primed cells (2  x  10  .~ cells per well) are then incubated with fresh 
restimulating (mitomycin C-treated) spleen cells (2  x  10  ~ cells per well) from various strains of 
mice in Linbro (IS-MRC-96-TC) round-bottom microtiter plates (Linbro Chemical Co., New Ha- 
ven, Conn.). Proliferative and cytotoxic responses are then measured on days 1-5 after secondary 
stimulation. 
CML.  The CML procedure has been described elsewhere (8).  Briefly, effector cells obtained 
from MLC are resuspended in EHAA plus 5% inactivated (56°C, 2 h) fetal calf serum (FCS) at the 
viable cell concentration to be used in the CML. Target cells are lymph node cells that have been 
stimulated  with  phytohemagglutinin-M for 48  h,  labeled  with  Na2:'lCrO4,  washed  in  Hanks' 
balanced  salt  solution,  and  resuspended in  EHAA  +  5%  FCS  (inactivated)  at  a  viable  cell 
concentration to yield 1 x  104 cells per effector-target mixture. Target and effector cells (100-~1 
portions of each) are incubated in Linbro round-bottom microtiter plates (no. IS-MRC-96; Linbro 
Chemical Co.) for 3-3.5 h after which the plates are centrifuged and ~lCr released in the supernate 
determined. Spontaneous release (SR) represents the counts per minute of the supernate from 1 × 
104 target cells alone. Maximum release (MR) is determined by detergent lysis of 1 x  104 target 
cells. Percent CML is calculated as follows: 
(cpm experimental release -  cpm SR)  x  100. 
(cpm MR -  cpm SR) 
Results 
Fig.  1 shows results  of a  typical  restimulation  experiment  where  primary 
sensitization to LD and SD differences is followed by secondary stimulation by 
these same antigenic differences.  The proliferative and cytotoxic responses at 
various times after initiation  of the primary and secondary cultures are given. 
By the time of restimulation the proliferative response of the primary MLC has 
diminished  and the primary  CML response,  while usually still  significant,  is 
also markedly reduced as compared with its peak response on day 5. Despite the 
remaining  CML on day 14, a  significant increase takes place within only 24 h 
after  restimulating  cells syngeneic to the  primary  stimulator  are  added;  the 
maximum cytotoxic response usually occurs between day 2 and day 4. Addition 
of restimulating  cells syngeneic with the  responding  cells has little  effect on 
either the proliferative or the cytotoxic responses. 
Role of LD in Restimulation.  We first tested the ability of LD differences 
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FIG. l.  Primary MLC and CML on  BI0.D2  target  cells  and  kinetics  of  secondary MLC and 
CML  on BI0.D2 target  cells.  B10 spleen cells  sensitized  to BI0.D2 mitomycin C-treated 
spleen  cells  are assayed for  primary  MLC (open  symbols) and CML (closed  symbols) on  day  5 
and day 14  of  culture.  On day 14,  primed  cells  are restimulated  (  T  )  with  media only (Q, O). 
B10m spleen cells  (1, [3),  or  B10.D2m spleen cells  (b, A). CML, expressed as percent CML; 
and MLC, as counts per minute of  incorporated  PH]TdR, are determined I, 2, 3, 4, and 5 
days  after  secondary stimulation.  All  points  shown for  cytotoxicity  are  effector:target  ratios 
of  30:1  and  are either  actual  values or  values  extrapolated  from  effector  to  target  ratio  from 
dose response curves of  at least  three point  determinations. 
and SD differences. B10.T(6R)  (qqqd) cells are sensitized in primary culture to 
B10.A (kkdd)  (LD and SD differences) and restimulated in the secondary phase 
with  AQR  (qkdd)  (LD  difference only).  Results  are  shown  in  Fig.  2.  After 
sensitization in the primary there is high level CML on B10.A with low level 
CML on B10.S and AQR. On day 16, 2 days after restimulation, excellent and 
rapid  CML  has  developed  against  the  B10.A  target  regardless  of whether 
restimulation is done with B10.A, AQR, or B10.S cells. Each of these cells also 
induces a "secondary-type"  proliferative response, i.e., a significant response by 
day 2 after restimulation (data not shown). Restimulation with AQR or B10.S in 
this experiment does not result in significant levels of CML directed at these 
targets within the first 2 days after restimulation. 
In  view of our recent findings that LD differences alone  are  sufficient to 
generate relatively weak, but significant, CML in primary culture (8,  9),  we 
have tested their ability to restimulate a secondary anti-"LD" CML response. As 
illustrated in Table I, using the LD disparate strains 6R (qqqd) and AQR (qkdd) 
for primary sensitization, secondary stimulation on day 14 with the original LD- 
different sensitizing strain (AQR) leads to a rapid proliferative response, which 
is comparable to that seen when both LD and SD differences are present in the 
two phases of the reaction (data not shown). Furthermore, 2 days after second- 
ary stimulation, the relatively low level cytotoxicity  directed at the LD-different 
sensitizing cell in the primary CML (day 5),  is enhanced to levels equal to or 
greater than those seen in the primary (Table I).  When cells from strain B10.A 
(kkdd)  are used to restimulate the 6R plus AQR~ sensitized culture, similar 1008  SECONDARY  CELL-MEDIATED  LYMPHOLYSIS 
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Fro.  2.  Cytotoxic  activity  of  primary  culture  sensitized  to  LD  and  SD  antigens  and 
restimulated with LD antigens alone or LD plus SD antigens. Part A shows the cytotoxic 
response of 6R spleen cells sensitized to BI0.A mitomycin C-treated spleen cells on day 5 of a 
primary response on target cells of B10.A (specific sensitizing strain, LD plus SD different 
from  6R),  AQR  (LD  identical  to  B10.A and LD  different from  6R),  B10.S  (LD  and  SD 
different), and 6R (control). On day 14, immediately before and the day of restimulation, the 
6R plus B10.Am sensitized cells gave the following CML response at 75:1 effector:target ratio 
on targets:B10.A,  22.5%; 6R,  -4.8%;  AQR,  -2.4%; and B10.S,  -2.7%.  Part B  shows the 
CML response on B10.A target cells 2 days after restimulation of the 6R plus B10.Am culture 
with AQRm, BI0.S~, B10.Am, or 6Rm. Cytotoxicity  on targets  AQR, BI0.S, and 6R ranged 
from -8.1 to 4.1%. 
secondary-type proliferative and cytotoxic responses result.  This is as expected 
since B10.A and AQR share the I  region and they presumably share the same 
LD.  The  question,  however,  remained  whether  after sensitization  to the pri- 
mary LD stimulus, the SD antigens of B10.A which differ from the responding 
6R cells would generate an additional cytotoxic response in the secondary. The 
results given in Table I are consistent with the concept that although  the SD 
antigens  of B10.A apparently  do not generate  additional  secondary-type cyto- 
toxic cells against themselves, at least at this early time of assay after restimu- 
lation, the LD differences of B10.A can substitute for those of AQR in restimula- 
tion of the anti-LD CML. 
Role of SD Antigens  in Restimulation.  After primary  stimulation  with  a 
combined LD and SD difference, target cells carrying the SD antigens  of the 
stimulating cell are lysed extensively in the CML assay. Target cells carrying 
SD antigens which are presumably cross-reactive with those of the sensitizing 
cell  (10)  can  be lysed to  a  lesser,  but significant,  extent.  These  same  cross- 
reacting strains  can, if used as donors of restimulating  cells, lead to the rapid 
development of CML against target cells from the original  sensitizing  strain, 
presumably at least in part, via LD stimulation of the culture. The experiments 
to be described below were done to test whether the SD antigens present on the 
restimulating cells in some way affect the magnitude or specificity of the CML 
response directed at the various targets. ALTER,  GRILLOT=COURVALIN,  BACH,  ZIER,  SONDEL,  AND  BACH  1009 
TABLE  I 
CML after Primary LD Sensitization and Secondary LD or LD plus SD Restimulation 
%  CML ±  SD of targets 
Effector: 
MLC (mean  Stimulus  Day of  target  B10.T (6R)  AQR (qkdd)  B10.A 
cpm  +_  SD)  assay  ratio  (qqqd)*  (kkdd) 
Primary 
30,862  ±  2,428  6R+ AQRm  5  75:1  4.8 ±  2.1  19.5  -+ 4.8  14.9 ±  2.2 
-  14  30:1  2.2  ±  1.5  -0.3  ±  2.1  - 
Secondary 
4,841  ±  1,367  +  6Rm  25  30:1  -7.5 ±  3.3  5.2  ±  7.6  - 
62,133  -+ 5,915  +  AQRm  2  30:1  -  33.1  ±  6.2  26.2 ±  1.7 
62,524 ±  3,093  +  B10.Am  2  30:1  -  24.6 _+  6.9  31.7  ±  2.6 
* Lowercase italic letters refer to the regions of the MHC as  described in the text. 
5 The day of assay of secondary cultures refers to the number of days after secondary stimulation 
(on day 14) when the CML and  MLC responses are determined. 
Cells of B10 (bbbb) were sensitized  in  a  primary  MLC  with cells of strain 
B10.D2 (dddd). These cultures were restimulated on day 14 with B10.D2, B10.G 
(qqqq), or B10.BR (kkkk). CML was tested on target cells of each strain. Results 
from one such experiment are given in Fig. 3. On day 5 after primary sensitiza- 
tion  with  B10.D2,  there  is  approximately  equal  cross-killing  on  B10.BR and 
B10.G targets.  The addition of any of these cells as restimuli results in strong 
killing  against  the  original  sensitizing  cell,  B10.D2  on  day  16,  2  days  after 
secondary stimulation  on day 14.  In addition,  these experiments  demonstrate 
that the SD antigens on either the B10.BR or the B10.G-restimulating  cell will 
"deviate" the response toward that particular cell. Note, for instance, that aider 
primary sensitization to B10.D2 and restimulation with B10.D2, there is slightly 
stronger cross-killing on B10.G than on B10.BR. Yet, if B10.BR is used as the 
restimulating cell, the CML on B10.BR is now greater than on B10.G; if B10.G is 
used as the restimulating  cell, the CML on B10.G is markedly greater than on 
B10.BR. Comparable results (not shown) have been obtained using B10.G as the 
primary sensitizing cell. In every case the level of CML in the secondary culture 
is maximal  against  the  target  syngeneic to the original  sensitizing  cell.  It is 
important to emphasize that the deviation of the respone noted above, presum- 
ably by the SD antigens on the restimulating cells, was observed in those cases 
where the restimulating cells were thought to have SD antigens cross-reactive 
with the  SD antigens  of the  original  sensitizing  cells,  as indicated  by cross- 
killing in the primary CML assay. 
Discussion 
The genetic and cellular dichotomy of MHC antigens that play a  role in the 
generation of a primary MLC-CML reaction has been intensively studied in the 
last few years (11-15). The finding that in primary MLC-CML the T-cell subpop- 
ulation that  mediates cytotoxicity is physically separable from the T-cell sub- 
population that is primarily responsible for the proliferative response in MLC 1010  SECONDARY CELL-MEDIATED  LYMPHOLYSIS 
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Fro.  3.  Secondary  stimulation  of B10  spleen  ceils  sensitized  to  mitomycin  C-treated 
B10.D2  spleen  cells by  strains  whose  SD  antigens  cross-react with those  of B10.D2 as 
determined by cross-killing in the day 5 primary CML response. Fig. 3 A shows the percent 
CML on the four given target cells (B10.D2, B10.BR, B10.G, and B10) on day 5 after primary 
sensitization. Fig. 3 B-D show the cytotoxicity on the same four target cells plus B10.S 2 
days after restimulation on day 14 with B10.D2m spleen cells (B), B10.BR~ spleen cells (C), 
and B10. Gm spleen cells (D). CML results were obtained 2 days later against the same four 
target cells plus B10.S. 
and cooperates (LD-reactive PHCs) in the generation of cytotoxic lymphocytes 
raises certain questions regarding possible roles of these two populations in the 
secondary response (16-19). 
Highly specific and efficient CTLs are generated after secondary stimulation. 
The restricted specificity of this response is probably based in part on a suppres- 
sor  mechanism  generated  in  MLC  (20).  In  terms  of positive  selection  in  the 
primary MLC, two possibilities for the cellular basis of the in vitro secondary ALTER,  GRILLOT-COURVALIN,  BACH,  ZIER,  SONDEL,  AND  BACH  1011 
response can be considered. It may be that incubation of the cells beyond their 
initial proliferative and cytotoxic peak allows the development of independent 
"memory" cells which are  qualitatively different from the cells responding to 
alloantigens  in the primary  MLC-CML culture.  Alternatively,  it may be that 
during the sensitization phase, the cells which have responded by differentiation 
and proliferation simply survive, preferentially leading to an increased percent- 
age of specifically responding cells; the magnitude,  kinetics,  and specificity of 
the secondary response would reflect this form of in vitro selection.  We shall 
refer to the lymphocytes responding  rapidly upon restimulation  as secondary 
lymphocytes without implying a  prejudice as to the mechanism  on which this 
response is based. 
Extensive cytotoxicity is generated after secondary stimulation.  One can only 
assume that these are secondary CTLs under one of the two mechanisms just 
discussed. The question whether there are also secondary PHCs that respond on 
restimulation is not clear although the data presented in this paper is consistent 
with  the  existence  of such  cells  based  on  the  extensive  early  proliferative 
response  that  may be  analogous to the  primary  response.  In  fact,  we would 
propose the  following model  to  account for restimulation  of the  cytotoxic re- 
sponse. 
After primary MLC sensitization both secondary PHCs and secondary CTLs 
are  generated.  In  the  primary  sensitization  phase  only the  CTL  precursors 
reactive to those SD antigens present might be activated; all other CTL precur- 
sors  reactive  to  SD  antigens  not  present  on  the  stimulating  cells  would be 
selected against,  and therefore are not present at the time of restimulation. 
For the primary CML response, the CTL may require two signals for activa- 
tion.  Signal  one  by  the  SD  antigen  leading  to  the  specificity  of the  CML 
response; signal two possibly given by the product(s) of the LD-stimulated PHC. 
We would hypothesize that in the secondary response, the CTLs responsive to 
the SD antigen present on the primary stimulating cell are "poised" to differen- 
tiate rapidly and may require only the cooperative signal two to be activated. 
However, while this may even be the prime mechanism for activating the CTLs 
in the secondary, the administration of signal one to the CTLs in the secondary 
may either increase the probability that the particular CTL in question will be 
triggered by signal two or may trigger that CTL alone. Other models to explain 
the data we have presented are discussed below. 
A role for the LD stimulus that fits our model is demonstrated in experiments 
where the primary stimulating  population differed from the responder by LD 
and SD antigens.  In the restimulation phase, LD differences alone were able to 
reactivate the specific anti-SO cytotoxic response (Fig.  2). Although we do not 
add the SD antigen upon restimulation in such experiments, it is possible that 
the SD antigens have, in some form, remained in culture since primary sensiti- 
zation.  The SD antigens may however not be needed in the secondary culture. 
Secondary CTL differentiation may, as discussed, require only the cooperative 
signal from LD-reactive PHCs or some substitute for this signal.  Further,  the 
relationship between the amount of PHC collaborative stimulus generated and 
the amount of CML may not be strictly linear but rather based on some needed 
threshold level of help. This would explain how LD-cross-reacting restimulating 1012  SECONDARY  CELL-MEDIATED  LYMPHOLYSIS 
cells, presumably bearing only some of the LD determinants to which cells were 
sensitized in the primary MLC,  were able to  induce the same level of CML 
activation to the original stimulating SD antigens as restimulating cells bearing 
the LD antigens present on the initial stimulator (Fig. 2). In man the magnitude 
of the proliferative response in secondary stimulation correlates with shared LD 
determinants; this has been used as a method for LD typing (4). 
Our findings could also be explained by cytophilic transfer of the LD antigen 
receptors to the specific SD-reactive cytotoxic cells in the primary culture such 
that the LD difference alone will activate these cells in the secondary (5). Other 
mechanisms by  which  LD  differences could  activate  CTLs  directly are  also 
possible. 
Restimulating SD antigens do affect the specificity of cytotoxicity generated 
in secondary cultures (Fig. 3). This is observed best when third-party cells that 
bear cross-reacting SD antigens with the primary stimulating cells, restimulate 
cytotoxic activity that ~'deviates" toward targets from that third party. If within 
the poised  population  of CTLs,  different subpopulations  exist,  each directed 
against specific SD determinants on the primary stimulator, but those subpopu- 
lations that also recognize the shared (or cross-reacting) SD  antigens on the 
third-party restimulating cells are most strongly activated, this would account 
for the deviation of the response toward the SD antigens present on the cross- 
reacting restimulating cell. A suppression mechanism to account for deviation is 
also possible. The specificity of this deviation (Fig. 3 C and D) indicates that the 
shared antigens recognized by B10 plus (B10.D2)m CTLs on B10.G targets are 
distinct from the shared antigens recognized on B10.BR. This is directly testable 
by CML-blocking experiments,  currently in progress,  using unlabeled "cold" 
cells in the CML assay. Preliminary blocking results in man suggest that the 
killing of third-party targets is mediated by recognition of antigens shared by 
the third-party and primary  stimulator,  rather than antigens unique to  the 
third party (21). The LD helper effect, presumably activated by cross-reacting 
LD  antigens  on  the third-party  cells  would promote the  development of all 
cytotoxic cells present in the culture after primary sensitization. Since the early 
secondary CML after restimulation would in all cases involve those CTLs which 
are active against the original sensitizing cell, this would explain the retention 
of maximal CML against that cell. 
It is not yet clear whether the killing directed at the LD antigens (Table I) is 
mediated by CTLs belonging to the same functional subpopulation of T  cells 
responsible for anti-SD killing in CML. (We recognize that the CML target in 
these  cases might  not  be  the LD  antigens per se but rather other antigens 
determined by closely linked loci.) It is our supposition that a distinct subpopu- 
lation of LD-reactive CTLs should be separable from the majority of LD-reactive 
cells which function as PHCs.  The arguments and model we have presented 
above can thus be extrapolated to these experimental results. The cellular basis 
of the secondary response may be best clarified by protocols using monolayer 
adsorption or anti-Ly antisera. 
We  have  recently published  results  which we  interpret  to  show  that  the 
primary response is  probably initiated by the SD  antigens and that the LD 
response  allows the expansion or differentiation of the anti-SD  cytotoxic re- ALTER,  GRILLOT-COURVALIN,  BACH,  ZIER,  SONDEL,  AND  BACH  1013 
sponse (9), in analogy with the model proposed by Dutton and Hunter (22) and 
Schimpl and Wecker (23) for the development of the antibody-forming response 
and the  role  of T  helper  cells  in that system.  We  extend this  model to the 
secondary-type response based on the results presented in this paper and postu- 
late  that  the  LD-responsive  PHC  is  present  in  the  secondary cultures  and 
responds, again primarily to LD. Further, similar to the primary, the LD helper 
effect permits reactivation of the SD-specific CTLs. 
Summary 
Lymphocytes stimulated in mixed leukocyte cultures and left for 13-17 days, 
i.e. beyond their peak proliferative and cytotoxic reactivities, can be restimu- 
lated  to  give  a  secondary-type rapid  and  strong  proliferative  and  cytotoxic 
response when confronted with cells of the original sensitizing cell donor.  We 
have concerned ourselves primarily with the requirements of restimulation for 
the presence of LD and/or SD stimuli on the restimulating cells. (a)  The low 
level  cell-mediated  lympholysis (CML)  associated  with  LD  differences in  a 
primary CML can be restimulated to give a  secondary-type response by those 
same LD antigens. (b) If the original sensitizing cells differ from the responding 
cells by both LD and SD antigens, restimulation with only the LD antigens, or 
third-party cells presumably carrying cross-reactive LD antigens, can restimu- 
late  the  secondary  CML response  directed  against the  SD  antigens  on  the 
original sensitizing cells. (c)  The presence of SD antigens on the restimulating 
cells  that  are  cross-reactive  with  the  primary  sensitizing  SD  antigens  (as 
determined in a primary CML) leads to the preferential activation of cytotoxic T 
lymphocytes reactive to those antigens although maximum cytotoxicity is still 
directed  at  cells  carrying the  original  sensitizing SD  antigens.  A  model  to 
explain these results is presented. 
Received for publication  1 December 1975. 
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